Brokerages Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Price Target at $59.20
Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) have received a consensus rating of “Buy” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month […]
Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) have received a consensus rating of “Buy” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month […]
